Company news

Aura Biosciences, Inc. news in 2025

Aura Biosciences, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

November 24, 2025

Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights

November 13, 2025

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

September 3, 2025

Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights

August 13, 2025

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

May 15, 2025

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

May 15, 2025

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

May 15, 2025

Aura Biosciences to Participate in Upcoming Investor Conferences

May 1, 2025

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

April 2, 2025

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

March 24, 2025

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

March 24, 2025

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

March 3, 2025

Decks in 2025